LTP Special Column

Categories
LTP Special Column (240) Fintech (24) Blockchain / Digital Asset (8) AI (16) ESG (22) Mergers & Acquisitions / Cross-border Investment (8) Capital Market / Securities (249) General Corporate Affairs (163) Infrastructure Projects / Construction Laws (110) Telecommunications and Media (1) Trade Secret (18) Trademark (46) Patent (35) Copyright (79) Competition Law (81) Biotech (37) Energy (14) Media / Entertainment (57) Employment Law (125) Personal Data Protection (41) Arbitration / Litigation (339) Tax (58) Environmental Protection Law (8) PRC Investment and Legal Compliance (31) Other Areas (233)

November 2024

Insight

Serials Research Part Three on the New Systems under the New Company Law: Exploring the Direct Compensation Liability of Directors and Senior Executives to Third Parties Under Article 191 of the New Company Law (Mainland China)

Jolene Chen

Teresa Huang

October 2024

Series Articles on Taiwan's New Anti-Fraud Laws and Regulations (2) – Which Advertising Platforms Are Regulated Under the Fraud Crime Prevention Act?

September 2024

Compliance Implications of the Draft Anti-Monopoly Guidelines for the Pharmaceutical Industry (Mainland China)

September 2024

Series Articles on Taiwan's New Anti-Fraud Laws and Regulations (1) – Corporate Cooperation Obligations and Preventive Measures under the Fraud Crime Prevention Act

Pei-Ching Ji

Aaron Chen

Doris Hsu

Chuck Liu

September 2024

Trademark Protection (6) – Key Points of Trademark Assignment (Mainland China)

September 2024

Series Articles of the Regenerative Medicine Dual Legislation (3) – The Impact of the Regenerative Medicine Dual Acts on the Therapy and Drug Development of Rare Diseases

Chung Teh Lee

Teresa Huang

Oli Wong

July 2024

Roll Your Own Bot: Notes on Law Firms Building Their Own Private AI Systems

July 2024

Series of Articles on Copyright Protection (4) ─ Remedies for Copyright Infringement (Mainland China)

July 2024

Series Articles of the Regenerative Medicine Dual Legislation (2) – Analysis of the Conditional Approval System for Regenerative Medicine Product

Teresa Huang

Hannah Kuo

David Hung

July 2024

Insight
Serials Research Part Two on the New Systems under the New Company Law: How to Transit from "Registered and Subscribed Capital System" Under the New Company Law? (Mainland China)

Jolene Chen

Teresa Huang
< 1 2 3 4 5 6 7 8 9 10 >

Tag Cloud